IRMA for Assessment of Soluble Platelet Glycocalicin and Its Clinical Application in Coronary Heart Disease

赵益明,何杨,沈文红,阮长耿
DOI: https://doi.org/10.3760/cma.j.issn.2095-2848.2005.06.019
2005-01-01
Abstract:Objective To establish the immunoradiometric assay(IRMA)method for assessment ot soluble platelet glycocalcin(sGC)and its clinical use.Methods The labeling of ~(125)I-2D4 was by chlora- mine T method.IRMA method was established for assessment of sGC.The plasma sGC levels of 50 healthy people,15 unstable angina(UA)and 37 acute myocardial infraction(AMI)were measured by IRMA.Re- sults The assaying range was 31.25~2000 μg/L.The sensitivity was 15 μg/L.The intra assay coeffi- cients of variation(CV)were 6.25%,4.35% and 3.99%(n=6)and the inter assay CV were 8.55%, 4.82% and 4.48% for 50,300,1800 μg/L,respectively.The average recovery rate was 101.88%.The plasma sGC level in normal group was(824.50±225.11)μg/L.The plasma sGC levels in both UA and AMI groups were significantly higher than that in normal group(P0.01).Coxregression analysis revealed that sGC was significantly correlated with P-selectin in AMI and UA groups(r=0.652,P0.01).Con- clusion The sGC may be an important molecular marker of platelet activation and destruetion.
What problem does this paper attempt to address?